The drug maker has received final approval from the US drug regulator to market butalbital, acetaminophen and caffeine tablets of various strengths.
This combination of medication is used to treat symptom complex of tension (or muscle contraction) headache.
"The drug will be manufactured at Nesher Pharma's manufacturing facility at St. Louis, USA," the company said in a regulatory filing made on Saturday (18 July 2020).
The group now has 294 approvals and has so far filed over 390 ANDAs (abbreviated new drug applications) since the commencement of the filing process in FY 2003-04.
Cadila is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies.
Cadila Healthcare's consolidated net profit fell 14.8% to Rs 391.90 crore on 0.21% rise in net sales at Rs 3,627.20 crore in Q4 FY20 over Q4 FY19.
The stock jumped 4.52% to Rs 377.25 on Friday (17 July).
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app